Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, announces the release of a key publication by scientists at Wenzhou Medical University, Wenzhou Central Hospital, The First Hospital of Kunming and Berry Genomics, a leading provider of solutions for pre-natal diagnostic testing in China.
February 11, 2019
· 2 min read